U.S., May 13 -- ClinicalTrials.gov registry received information related to the study (NCT07580521) titled 'Microneedling for Androgenic Alopecia: a Clinical Study' on April 27.
Brief Summary: A total of 20-30 patients with mild to moderate androgenic alopecia are expected to be enrolled. Inclusion criteria are patients aged >=22 years; for males, Norwood's grading II-IV, and for females, Ludwig stage I-II. After enrollment, one researcher will use computer-generated randomization to assign each side of the patient's scalp to either the experimental group or the control group. The scalp side allocated to the experimental group will receive microneedling treatment once every two weeks (at baseline, and at weeks 2, 4, 6, 8, and 10; six sessi...